ResearcherThe Ohio State University Wexner Medical CenterNo recent work listed

Lena Schreiber

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0958-0035; OpenAlex author ID A5037144616. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2022: 1 paper

Papers 1

Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2021.10.010 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eric David Miller · 1 shared paper, 2022 · strength 0.15
- Paper Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic du… DOI 10.1016/j.hpb.2021.10.010 ↗
Heena P. Santry · 1 shared paper, 2022 · strength 0.15
- Paper Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic du… DOI 10.1016/j.hpb.2021.10.010 ↗
Allan Tsung · 1 shared paper, 2022 · strength 0.15
- Paper Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic du… DOI 10.1016/j.hpb.2021.10.010 ↗
Jordan M. Cloyd · 1 shared paper, 2022 · strength 0.15
- Paper Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic du… DOI 10.1016/j.hpb.2021.10.010 ↗
Somashekar Gopala Krishna · 1 shared paper, 2022 · strength 0.15
- Paper Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic du… DOI 10.1016/j.hpb.2021.10.010 ↗
Timothy Michael Pawlik · 1 shared paper, 2022 · strength 0.15
- Paper Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic du… DOI 10.1016/j.hpb.2021.10.010 ↗
Anne M. Noonan · 1 shared paper, 2022 · strength 0.15
- Paper Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic du… DOI 10.1016/j.hpb.2021.10.010 ↗
Aslam M. Ejaz · 1 shared paper, 2022 · strength 0.15
- Paper Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic du… DOI 10.1016/j.hpb.2021.10.010 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.